Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells

Photodiagnosis and Photodynamic Therapy

Volumn 11, Issue 2, 2014, Pages 193-203

  Shemesh, Colby S ^a   Hardy, Claire W ^b   Yu, David S ^b   Fernandez, Brian ^a   Zhang, Hailing ^a  

^a MERCER UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage; Indocyanine green (ICG); Photodynamic therapy (PDT); Thermosensitive liposome; Triple negative breast cancer (TNBC)

Indexed keywords

INDOCYANINE GREEN; LIPOSOME; NANOCARRIER; NANOCAPSULE; RADIOSENSITIZING AGENT;

ARTICLE; BREAST EPITHELIUM; CANCER CELL LINE; CANCER INHIBITION; CELL VIABILITY; CLONOGENIC ASSAY; COMPARATIVE STUDY; CYTOTOXICITY; DIODE LASER; DOUBLE STRANDED DNA BREAK; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIPOSOMAL DELIVERY; MTT ASSAY; MUTAGENICITY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; APOPTOSIS; CELL SURVIVAL; CHEMISTRY; DIFFUSION; DRUG EFFECTS; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE; ULTRASTRUCTURE;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DIFFUSION; HUMANS; INDOCYANINE GREEN; LIPOSOMES; NANOCAPSULES; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84901610975     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2014.02.001     Document Type: Article

References (22)

1. American Cancer Society Cancer Facts & Figures 2012, Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf [accessed November 2012].
2. de-Ruijter T.C., Veeck J., de-Hoon J.P.J., van-Engeland M., Tjan-Heijnen V.C. Characteristics of triple-negative breast cancer. J Cancer Res Clin Oncol 2011, 137:183-192.
3. Gelmon K., Dent R., Mackey J.R., Laing K., McLeod D., Verma S. Targeting triple-negative breast cancer: optimising therapeutic outcomes. Ann Oncol 2012, 23:2223-2234.
4. Gluz O., Liedtke C., Gottschalk N., Pusztai L., Nitz U., Harbeck N. Triple-negative breast cancer-current status and future directions. Ann Oncol 2009, 20:1913-1927.
5. Pal S.K., Childs B.H., Pegram M. Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat 2011, 125:627-636.
6. Dolmans D.E., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
7. Alli E., Sharma V.B., Sunderesakumar P., Ford J.M. Defective repair of oxidative DNA damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. Cancer Res 2009, 69:3589-3596.
8. Ghoroghchian P.P., Therien M.J., Hammer D.A. In vivo fluorescence imaging: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:156-167.
9. Hilderbrand S.A., Weissleder R. Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 2010, 14:71-79.
10. Licha K., Riefke B., Ntziachristos V., Becker A., Chance B., Semmler W. Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization. Photochem Photobiol 2000, 72:392-398.
11. Saxena V., Sadoqi M., Shao J. Degradation kinetics of indocyanine green in aqueous solution. J Pharm Sci 2003, 92:2090-2097.
12. Turner D.C., Moshkelani D., Shemesh C.S., Luc D., Zhang H. Near-infrared image-guided delivery and controlled release using optimized thermosensitive liposomes. Pharm Res 2012, 29:2092-2103.
13. Zhu L., Banerjee R.K., Salloum M., Bachmann A., Flower R.W. Temperature distribution during ICG-dye-enhanced laser photocoagulation of feeder vessels in treatment of AMD-related choroidal neovascularization. J Biomech Eng 2008, 130:031010.
14. Shahzidi S., Cunderlikova B., Wiedlocha A., Zhen Y., Vasovic V., Nesland J.M., et al. Simultaneously targeting mitochondria and endoplasmic reticulum by photodynamic therapy induces apoptosis in human lymphoma cells. Photochem Photobiol Sci 2011, 10:1773-1782.
15. Ali-Seyed M., Bhuvaneswari R., Soo K.C., Olivo M. Photolon™-photosensitization induces apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes. Int J Oncol 2011, 39:821-831.
16. Rosenkranz A.A., Jans D.A., Sobolev A.S. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol Cell Biol 2000, 78:452-464.
17. Chen C.Y., Fancher R.M., Ruan Q., Marathe P., Rodrigues A.D., Yang Z. A liquid chromatography tandem mass spectrometry method for the quantification of indocyanine green in dog plasma and bile. J Pharm Biomed Anal 2008, 47:351-359.
18. Lehmann B.D., Bauer J.A., Chen X., Sanders M.E., Chakravarthy A.B., Shyr Y., et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 2011, 121:2750-2767.
19. Takahashi A., Ohnishi T. Does gammaH2AX foci formation depend on the presence of DNA double strand breaks?. Cancer Lett 2005, 229:171-179.
20. Cai Z., Chen Z., Bailey K.E., Scollard D.A., Reilly R.M., Vallis K.A. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF. J Nucl Med 2008, 49:1353-1361.
21. Bonner W.M., Redon C.E., Dickey J.S., Nakamura A.J., Sedelnikova O.A., Solier S., et al. GammaH2AX and cancer. Nat Rev Cancer 2008, 8:957-967.
22. Ivashkevich A., Redon C.E., Nakamura A.J., Martin R.F., Martin O.A. Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett 2012, 327:123-133.